LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-edge Therapeutics TRexBio is developing novel therapies for immune-mediated diseases by mapping human tissue Treg behavior, presenting a prime opportunity for pharmaceutical partnerships to leverage their revolutionary approach to immune homeostasis restoration.

Strategic Collaboration The recent exclusive worldwide license agreement with Eli Lilly and Company signifies TRexBio's commitment to innovation and strategic partnerships, opening doors for collaborative sales initiatives within the biotechnology industry.

Funding for Growth With $26M in funding and a revenue range of $0 - 10M, TRexBio is poised for expansion, making them an attractive target for sales professionals looking to offer solutions and services that align with the company's growth trajectory.

Tech Stack Alignment TRexBio's tech stack includes GitHub, Java, and Linux among others, indicating a tech-savvy approach that aligns with modern trends, providing opportunities for tech-centric sales engagements tailored to their platform.

Competitive Landscape By contrasting with similar companies like Trefoil Therapeutics, OraSure Technologies, Inozyme Pharma, and Orbit Discovery, sales teams can identify market positioning strategies to showcase TRexBio's unique value proposition and differentiation in the biotechnology research sector.

Similar companies to TRexBio

TRexBio Tech Stack

TRexBio uses 8 technology products and services including GitHub, Font Awesome, jQuery, and more. Explore TRexBio's tech stack below.

  • GitHub
    Communication And Collaboration
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Choices
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Java
    Programming Languages
  • Linux
    Programming Languages
  • Gravity Forms
    Web Platform Extensions

TRexBio's Email Address Formats

TRexBio uses at least 1 format(s):
TRexBio Email FormatsExamplePercentage
FLast@trex.bioJDoe@trex.bio
84%
First@trex.bioJohn@trex.bio
13%
Last@trex.bioDoe@trex.bio
2%
FiLast@trex.bioJoDoe@trex.bio
1%

Frequently Asked Questions

Where is TRexBio's headquarters located?

Minus sign iconPlus sign icon
TRexBio's main headquarters is located at 681 Gateway Blvd 4th Floor South San Francisco, California 94080 US. The company has employees across 2 continents, including North AmericaEurope.

What is TRexBio's official website and social media links?

Minus sign iconPlus sign icon
TRexBio's official website is trex.bio and has social profiles on LinkedIn.

How much revenue does TRexBio generate?

Minus sign iconPlus sign icon
As of September 2024, TRexBio's annual revenue reached $3.8M.

What is TRexBio's SIC code NAICS code?

Minus sign iconPlus sign icon
TRexBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does TRexBio have currently?

Minus sign iconPlus sign icon
As of September 2024, TRexBio has approximately 54 employees across 2 continents, including North AmericaEurope. Key team members include Chief Operating Officer: L. B.Chief Scientific Officer: M. K.Vice President And Head Of Translational Biology: M. T.. Explore TRexBio's employee directory with LeadIQ.

What industry does TRexBio belong to?

Minus sign iconPlus sign icon
TRexBio operates in the Biotechnology Research industry.

What technology does TRexBio use?

Minus sign iconPlus sign icon
TRexBio's tech stack includes GitHubFont AwesomejQueryChoicesMicrosoftJavaLinuxGravity Forms.

What is TRexBio's email format?

Minus sign iconPlus sign icon
TRexBio's email format typically follows the pattern of . Find more TRexBio email formats with LeadIQ.

How much funding has TRexBio raised to date?

Minus sign iconPlus sign icon
As of September 2024, TRexBio has raised $26M in funding. The last funding round occurred on Mar 08, 2022 for $26M.

When was TRexBio founded?

Minus sign iconPlus sign icon
TRexBio was founded in 2018.
TRexBio

TRexBio

Biotechnology ResearchCalifornia, United States51-200 Employees

TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis. TRexBio is headquartered in South San Francisco, California.

Section iconCompany Overview

Headquarters
681 Gateway Blvd 4th Floor South San Francisco, California 94080 US
Website
trex.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $26M

    TRexBio has raised a total of $26M of funding over 2 rounds. Their latest funding round was raised on Mar 08, 2022 in the amount of $26M.

  • $10M

    TRexBio's revenue is in the range of $10M

Section iconFunding & Financials

  • $26M

    TRexBio has raised a total of $26M of funding over 2 rounds. Their latest funding round was raised on Mar 08, 2022 in the amount of $26M.

  • $10M

    TRexBio's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.